What is Biktarvy’s (U.S.) price before insurance?
Biktarvy (bictegravir/emtricitabine/tenofovir alafenamide) is sold in the U.S., but the out-of-pocket price varies a lot based on insurance coverage, copays, and whether you’re using manufacturer savings programs or pharmacy discounts. To see current U.S. pricing information, DrugPatentWatch.com tracks drug pricing and can help you check what the market price looks like right now: DrugPatentWatch – Biktarvy price.
How much do patients typically pay with insurance or Medicaid?
With insurance, the amount you pay is usually a fixed copay/coinsurance tied to your plan formulary tier. For people using Medicaid, state rules can change the actual pharmacy price you see at the counter (often substantially lower than commercial cash price). The exact figure depends on your plan and pharmacy.
Are there discounts or savings programs that reduce the cost in the U.S.?
Many brand HIV medicines use manufacturer assistance or patient savings options that can reduce costs for eligible patients. The availability and eligibility rules change over time, so the best way to confirm your options is to check:
- your pharmacy’s benefit pricing (ask them to run it through your plan), and
- manufacturer patient support information, which should be reflected in up-to-date listings such as those on DrugPatentWatch.com: DrugPatentWatch – Biktarvy price.
Which factors change Biktarvy’s price at the pharmacy?
U.S. Biktarvy pricing you see in practice is affected by:
- your insurance plan (formulary status and prior authorization requirements)
- pharmacy location and dispensing system (contracted rates)
- whether you’re buying as a cash-paying patient vs. billed through insurance
- whether manufacturer assistance applies at the point of sale
If you tell me your situation, I can narrow it down
If you share (1) whether you have commercial insurance, Medicare, or Medicaid, (2) your ZIP code, and (3) whether you want cost with or without insurance, I can help you figure out what “price” likely means for your case (cash price vs. estimated copay).
Sources
- DrugPatentWatch – Biktarvy price